Table of Contents

1 Study Coverage

• 1.1 Pruritus Therapeutics Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Pruritus Therapeutics Market Size Growth Rate by Product
  • 1.4.2 Corticosteroids
  • 1.4.3 Antihistamines
  • 1.4.4 Local Anesthetics
  • 1.4.5 Counterirritants
  • 1.4.6 Immunosuppressant
  • 1.4.7 Calcineurin Inhibitors
  • 1.4.8 Other Pruritus Therapeutics
• 1.5 Market by End User
  • 1.5.1 Global Pruritus Therapeutics Market Size Growth Rate by End User
  • 1.5.2 Atopic Dermatitis
  • 1.5.3 Allergic Contact Dermatitis
  • 1.5.4 Urticaria
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Pruritus Therapeutics Market Size
  • 2.1.1 Global Pruritus Therapeutics Revenue 2014-2025
  • 2.1.2 Global Pruritus Therapeutics Sales 2014-2025
• 2.2 Pruritus Therapeutics Growth Rate by Regions
  • 2.2.1 Global Pruritus Therapeutics Sales by Regions
  • 2.2.2 Global Pruritus Therapeutics Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Pruritus Therapeutics Sales by Manufacturers
  • 3.1.1 Pruritus Therapeutics Sales by Manufacturers
  • 3.1.2 Pruritus Therapeutics Sales Market Share by Manufacturers
  • 3.1.3 Global Pruritus Therapeutics Market Concentration Ratio (CR5 and HHI)
• 3.2 Pruritus Therapeutics Revenue by Manufacturers
  • 3.2.1 Pruritus Therapeutics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Pruritus Therapeutics Revenue Share by Manufacturers (2014-2019)
• 3.3 Pruritus Therapeutics Price by Manufacturers
• 3.4 Pruritus Therapeutics Manufacturing Base Distribution, Product Types
  • 3.4.1 Pruritus Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Pruritus Therapeutics Product Type
  • 3.4.3 Date of International Manufacturers Enter into Pruritus Therapeutics Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Pruritus Therapeutics Sales by Product
• 4.2 Global Pruritus Therapeutics Revenue by Product
• 4.3 Pruritus Therapeutics Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Pruritus Therapeutics Breakdown Data by End User

6 North America

• 6.1 North America Pruritus Therapeutics by Countries
  • 6.1.1 North America Pruritus Therapeutics Sales by Countries
  • 6.1.2 North America Pruritus Therapeutics Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Pruritus Therapeutics by Product
• 6.3 North America Pruritus Therapeutics by End User

7 Europe

• 7.1 Europe Pruritus Therapeutics by Countries
  • 7.1.1 Europe Pruritus Therapeutics Sales by Countries
  • 7.1.2 Europe Pruritus Therapeutics Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Pruritus Therapeutics by Product
• 7.3 Europe Pruritus Therapeutics by End User

8 Asia Pacific

• 8.1 Asia Pacific Pruritus Therapeutics by Countries
  • 8.1.1 Asia Pacific Pruritus Therapeutics Sales by Countries
  • 8.1.2 Asia Pacific Pruritus Therapeutics Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Pruritus Therapeutics by Product
• 8.3 Asia Pacific Pruritus Therapeutics by End User

9 Central & South America

• 9.1 Central & South America Pruritus Therapeutics by Countries
  • 9.1.1 Central & South America Pruritus Therapeutics Sales by Countries
  • 9.1.2 Central & South America Pruritus Therapeutics Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Pruritus Therapeutics by Product
• 9.3 Central & South America Pruritus Therapeutics by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Pruritus Therapeutics by Countries
  • 10.1.1 Middle East and Africa Pruritus Therapeutics Sales by Countries
  • 10.1.2 Middle East and Africa Pruritus Therapeutics Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Pruritus Therapeutics by Product
• 10.3 Middle East and Africa Pruritus Therapeutics by End User

11 Company Profiles

• 11.1 Sanofi
  • 11.1.1 Sanofi Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Sanofi Pruritus Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Sanofi Pruritus Therapeutics Products Offered
  • 11.1.5 Sanofi Recent Development
• 11.2 Pfizer
  • 11.2.1 Pfizer Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Pfizer Pruritus Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Pfizer Pruritus Therapeutics Products Offered
  • 11.2.5 Pfizer Recent Development
• 11.3 Tai Guk Pharmaceutical Company
  • 11.3.1 Tai Guk Pharmaceutical Company Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Tai Guk Pharmaceutical Company Pruritus Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Tai Guk Pharmaceutical Company Pruritus Therapeutics Products Offered
  • 11.3.5 Tai Guk Pharmaceutical Company Recent Development
• 11.4 Actavis
  • 11.4.1 Actavis Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Actavis Pruritus Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Actavis Pruritus Therapeutics Products Offered
  • 11.4.5 Actavis Recent Development
• 11.5 Trevi Therapeutics
  • 11.5.1 Trevi Therapeutics Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Trevi Therapeutics Pruritus Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Trevi Therapeutics Pruritus Therapeutics Products Offered
  • 11.5.5 Trevi Therapeutics Recent Development
• 11.6 Cara Therapeutics
  • 11.6.1 Cara Therapeutics Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Cara Therapeutics Pruritus Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Cara Therapeutics Pruritus Therapeutics Products Offered
  • 11.6.5 Cara Therapeutics Recent Development
• 11.7 Ocera Therapeutics Inc.
  • 11.7.1 Ocera Therapeutics Inc. Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Ocera Therapeutics Inc. Pruritus Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Ocera Therapeutics Inc. Pruritus Therapeutics Products Offered
  • 11.7.5 Ocera Therapeutics Inc. Recent Development
• 11.8 NeRRe Therapeutics
  • 11.8.1 NeRRe Therapeutics Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 NeRRe Therapeutics Pruritus Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 NeRRe Therapeutics Pruritus Therapeutics Products Offered
  • 11.8.5 NeRRe Therapeutics Recent Development

12 Future Forecast

• 12.1 Pruritus Therapeutics Market Forecast by Regions
  • 12.1.1 Global Pruritus Therapeutics Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Pruritus Therapeutics Revenue Forecast by Regions 2019-2025
• 12.2 Pruritus Therapeutics Market Forecast by Product
  • 12.2.1 Global Pruritus Therapeutics Sales Forecast by Product 2019-2025
  • 12.2.2 Global Pruritus Therapeutics Revenue Forecast by Product 2019-2025
• 12.3 Pruritus Therapeutics Market Forecast by End User
• 12.4 North America Pruritus Therapeutics Forecast
• 12.5 Europe Pruritus Therapeutics Forecast
• 12.6 Asia Pacific Pruritus Therapeutics Forecast
• 12.7 Central & South America Pruritus Therapeutics Forecast
• 12.8 Middle East and Africa Pruritus Therapeutics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Pruritus Therapeutics Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Pruritus Therapeutics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pruritus Therapeutics market based on company, product type, end user and key regions.

This report studies the global market size of Pruritus Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pruritus Therapeutics in these regions.
This research report categorizes the global Pruritus Therapeutics market by top players/brands, region, type and end user. This report also studies the global Pruritus Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
Pfizer
Tai Guk Pharmaceutical Company
Actavis
Trevi Therapeutics
Cara Therapeutics
Ocera Therapeutics Inc.
NeRRe Therapeutics

Market size by Product
Corticosteroids
Antihistamines
Local Anesthetics
Counterirritants
Immunosuppressant
Calcineurin Inhibitors
Other Pruritus Therapeutics
Market size by End User
Atopic Dermatitis
Allergic Contact Dermatitis
Urticaria
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Pruritus Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Pruritus Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pruritus Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pruritus Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Pruritus Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pruritus Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.